Newsletter – November 16th 2022
Upperton Launches ASAPprime® Shelf-Life Stability Testing Upperton has made a significant investment in ASAPprime® software and hardware to enable the company to offer its clients
Menu
News
Newsletter
Newsletter – September 15th 2022
In Vitro Testing of Dry Powder Nasal Delivery Devices Successful nasal drug delivery of dry powder formulations requires a delivered dose that can penetrate beyond
Newsletter – August 16th 2022
Latest News from Upperton Pharma Solutions Successful MHRA Inspection Upperton is delighted to announce that during the last week of July 2022 the UK MHRA
Press releases
Upcoming Events For 2023
